The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals. The actions represent the ...
The global generic drugs market size was estimated at USD 468.08 billion in 2025 and is predicted to increase from USD 491.67 ...
Add Yahoo as a preferred source to see more of our stories on Google. Draft guidance from the FDA would allow companies to scale back on the studies and trials needed to prove that a biosimilar ...
Gottlieb is a senior fellow at the American Enterprise Institute and served as commissioner of the Food and Drug Administration from 2017 to 2019. President Trump often touted during his first term ...
The Centers for Medicare & Medicaid Services just announced the next 15 brand-name medicines selected for Medicare’s drug price negotiation program, which mandates price reductions of at least 25%.
Forbes contributors publish independent expert analyses and insights. Sally Pipes is a scholar and think tank CEO who writes on health care. America’s generic drug market is one of our greatest health ...
Sen. Rick Scott (R-Fla.) on Thursday unveiled legislation that would require prescription drug labels to include information ...
The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...
Generic medications are not the same as brand medications. Small differences in ingredients that are permitted by the FDA may ...
The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results